Xenon Pharmaceuticals (XENE) Times Interest Earned (2013 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Times Interest Earned came in at -$13.57 in Q1 2026, down 81.79% year-on-year from -$74.53 in Q1 2025, and up 94.63% on a QoQ basis from -$252.92 in Q4 2025.
Xenon Pharmaceuticals (XENE) Times Interest Earned (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 14 years of Times Interest Earned data on file, last reported at -$13.57 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 81.79% year-over-year to -$13.57 in Q1 2026; TTM through Mar 2026 was -$49.87, a 65.79% decrease from a year earlier, with the FY2025 full-year figure at -$1.08, up 57.17% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$13.57, up from -$252.92 in the prior quarter.
- Over the last five years, Times Interest Earned for XENE reached as high as -$1.5 in Q1 2022 and fell as low as -$252.92 in Q4 2025.
- Historically, Times Interest Earned has averaged -$56.93 across 5 years, with a median of -$19.4 in 2022.
- Across the five-year window, Times Interest Earned soared 94.63% in 2022 and plunged 1705.78% in 2023, its largest moves.
- Year by year, Times Interest Earned stood at -$154.2 in 2022, then climbed by 14.02% to -$132.58 in 2023, then tumbled by 36.86% to -$181.44 in 2024, then slumped by 39.39% to -$252.92 in 2025, then jumped by 94.63% to -$13.57 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$13.57 in Q1 2026, -$252.92 in Q4 2025, and -$10.39 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | -13.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.57 |
| Dec 31, 2025 | -252.92 |
| Sep 30, 2025 | -10.39 |
| Jun 30, 2025 | -91.22 |
| Mar 31, 2025 | -7.47 |
| Dec 31, 2024 | -181.44 |
| Sep 30, 2024 | -6.64 |
| Jun 30, 2024 | -6.05 |
| Mar 31, 2024 | -4.95 |
| Dec 31, 2023 | -132.58 |
| Sep 30, 2023 | -4.38 |
| Jun 30, 2023 | -24.09 |
| Mar 31, 2023 | -27.01 |
| Dec 31, 2022 | -154.20 |
| Sep 30, 2022 | -19.40 |
| Jun 30, 2022 | -30.01 |
| Mar 31, 2022 | -1.50 |
| Dec 31, 2021 | -121.16 |
| Sep 30, 2021 | -27.32 |
| Jun 30, 2021 | -38.52 |